Merit Medical Systems Net Income
| MMSI Stock | USD 80.97 2.11 2.68% |
As of the 13th of February 2026, Merit Medical secures the Mean Deviation of 1.29, standard deviation of 1.81, and Risk Adjusted Performance of (0.06). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Merit Medical Systems, as well as the relationship between them.
Merit Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.5531 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 138.4 M | 145.3 M | |
| Net Income Applicable To Common Shares | 85.7 M | 90 M | |
| Net Income From Continuing Ops | 138.4 M | 145.3 M | |
| Net Income Per Share | 1.86 | 1.95 | |
| Net Income Per E B T | 0.72 | 0.62 |
Merit | Net Income | Build AI portfolio with Merit Stock |
The Net Income trend for Merit Medical Systems offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Merit Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Merit Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Merit Medical Systems over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Merit Medical Systems financial statement analysis. It represents the amount of money remaining after all of Merit Medical Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Merit Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 120.36 M | 10 Years Trend |
|
Net Income |
| Timeline |
Merit Net Income Regression Statistics
| Arithmetic Mean | 47,791,096 | |
| Geometric Mean | 26,623,299 | |
| Coefficient Of Variation | 102.10 | |
| Mean Deviation | 39,380,359 | |
| Median | 23,802,000 | |
| Standard Deviation | 48,793,847 | |
| Sample Variance | 2380.8T | |
| Range | 155.2M | |
| R-Value | 0.80 | |
| Mean Square Error | 903.1T | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | 7,756,435 | |
| Total Sum of Squares | 38093.4T |
Merit Net Income History
Other Fundumenentals of Merit Medical Systems
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Merit Medical Net Income component correlations
Merit Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Merit Medical is extremely important. It helps to project a fair market value of Merit Stock properly, considering its historical fundamentals such as Net Income. Since Merit Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Merit Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Merit Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Earnings Share 1.95 | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets |
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Merit Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Merit Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Merit Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Merit Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Merit Medical Systems or generate 0.0% return on investment in Merit Medical over 90 days. Merit Medical is related to or competes with Inspira Technologies, Biomerica, Heart Test, STRATA Skin, Aptevo Therapeutics, Advanced Biomed, and Burning Rock. Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional,... More
Merit Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Merit Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Merit Medical Systems upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 11.35 | |||
| Value At Risk | (2.64) | |||
| Potential Upside | 2.73 |
Merit Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Merit Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Merit Medical's standard deviation. In reality, there are many statistical measures that can use Merit Medical historical prices to predict the future Merit Medical's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (0.19) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Merit Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Merit Medical February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.18) | |||
| Mean Deviation | 1.29 | |||
| Coefficient Of Variation | (1,277) | |||
| Standard Deviation | 1.81 | |||
| Variance | 3.28 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (0.19) | |||
| Maximum Drawdown | 11.35 | |||
| Value At Risk | (2.64) | |||
| Potential Upside | 2.73 | |||
| Skewness | (0.66) | |||
| Kurtosis | 2.99 |
Merit Medical Systems Backtested Returns
Merit Medical Systems has Sharpe Ratio of -0.0668, which conveys that the firm had a -0.0668 % return per unit of risk over the last 3 months. Merit Medical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Merit Medical's Standard Deviation of 1.81, risk adjusted performance of (0.06), and Mean Deviation of 1.29 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.81, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Merit Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Merit Medical is expected to be smaller as well. At this point, Merit Medical Systems has a negative expected return of -0.12%. Please make sure to verify Merit Medical's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Merit Medical Systems performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.06 |
Very weak reverse predictability
Merit Medical Systems has very weak reverse predictability. Overlapping area represents the amount of predictability between Merit Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Merit Medical Systems price movement. The serial correlation of -0.06 indicates that barely 6.0% of current Merit Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.06 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 15.44 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Merit Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Merit Medical Systems reported net income of 120.36 M. This is 64.73% lower than that of the Health Care Equipment & Supplies sector and 20.8% higher than that of the Health Care industry. The net income for all United States stocks is 78.92% higher than that of the company.
Merit Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merit Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merit Medical could also be used in its relative valuation, which is a method of valuing Merit Medical by comparing valuation metrics of similar companies.Merit Medical is currently under evaluation in net income category among its peers.
Merit Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Merit Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Merit Medical's managers, analysts, and investors.Environmental | Governance | Social |
Merit Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Merit Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Merit Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Merit Medical's value.| Shares | Dimensional Fund Advisors, Inc. | 2025-06-30 | 1.1 M | Royal Bank Of Canada | 2025-06-30 | 1.1 M | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1 M | Franklin Resources Inc | 2025-06-30 | 884.6 K | Jpmorgan Chase & Co | 2025-06-30 | 852.2 K | Loomis, Sayles & Company Lp | 2025-06-30 | 793.7 K | Westwood Holdings Group Inc | 2025-06-30 | 769 K | Goldman Sachs Group Inc | 2025-06-30 | 756.9 K | William Blair Investment Management, Llc | 2025-06-30 | 739.6 K | Blackrock Inc | 2025-06-30 | 8.7 M | Vanguard Group Inc | 2025-06-30 | 6.8 M |
Merit Fundamentals
| Return On Equity | 0.083 | ||||
| Return On Asset | 0.0428 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 5.25 B | ||||
| Shares Outstanding | 59.29 M | ||||
| Shares Owned By Insiders | 2.22 % | ||||
| Shares Owned By Institutions | 97.78 % | ||||
| Number Of Shares Shorted | 3.81 M | ||||
| Price To Earning | 956.67 X | ||||
| Price To Book | 3.15 X | ||||
| Price To Sales | 3.26 X | ||||
| Revenue | 1.36 B | ||||
| Gross Profit | 715.9 M | ||||
| EBITDA | 273.97 M | ||||
| Net Income | 120.36 M | ||||
| Cash And Equivalents | 51.48 M | ||||
| Cash Per Share | 0.91 X | ||||
| Total Debt | 794.66 M | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 2.35 X | ||||
| Book Value Per Share | 25.80 X | ||||
| Cash Flow From Operations | 220.8 M | ||||
| Short Ratio | 5.03 X | ||||
| Earnings Per Share | 1.95 X | ||||
| Price To Earnings To Growth | 1.71 X | ||||
| Target Price | 104.27 | ||||
| Number Of Employees | 7.4 K | ||||
| Beta | 0.61 | ||||
| Market Capitalization | 4.82 B | ||||
| Total Asset | 2.42 B | ||||
| Retained Earnings | 695.54 M | ||||
| Working Capital | 707.37 M | ||||
| Current Asset | 204 M | ||||
| Current Liabilities | 87.91 M | ||||
| Net Asset | 2.42 B |
About Merit Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merit Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merit Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merit Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Earnings Share 1.95 | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets |
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.